In addition to the collaborative efforts of Drs. Himmelfarb and Ratner to revolutionize kidney dialysis we are bringing physicians, engineers, scientists and kidney patients together to address each of the major kidney dialysis complications. Teams focused on bioengineering and kidney research will collaborate on priority research projects.
Dr. Jonathan Himmelfarb, MD, is Co-Director of the Center for Dialysis Innovation, Director of the Kidney Research Institute, Joseph W. Eschbach, MD Endowed Chair in Kidney Research, and Professor of Medicine in Nephrology at the University of Washington.
Dr. Buddy Ratner, PhD, is Co-Director of CDI, Director of the Engineered Biomaterials Engineering Research Center, Michael L. and Myrna Darland Endowed Chair in Technology Commercialization, and Professor in Bioengineering and Chemical Engineering at the University of Washington.
Dr. Larry Kessler, ScD, is the Director of Regulatory Oversight for the Center for Dialysis Innovation, and Professor in the Department of Health Services in the School of Public Health at the University of Washington.
Dr. Kassandra Thomson, PhD, is the Director of Translational Research and Commercialization for the Center for Dialysis Innovation.
Dr. Anna Galperin, PhD, is CDI's Director of Research and Development. She received her MSc in Medicinal Organic Chemistry in 2000 and graduated with a PhD in Polymer Chemistry in 2006 from Bar-Ilan University, Israel.
Glenda V. Roberts is the Director of External Relations and Patient Engagement for the Center of Dialysis Innovation (CDI). She received her BS in Mathematics from the University of Houston in Houston, Texas.
Barry N. Fulkerson is the UW Center for Dialysis Innovation Director of Systems Engineering and a Medical Products R&D Executive, offering direct medical device innovation and product development experience developing extracorporeal systems in start-up and established environments. Based on partnerships